Live Breaking News & Updates on Pfizer Corona Vaccine
Stay updated with breaking news from Pfizer corona vaccine. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
American Pharma giant Pfizer has operationalized its largest and only drug development centre in Asia in the Indian city of Chennai. Set up at a cost of USD20 million (approx INR150 crore), the facility will carry out the development of Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms (FDFs) for a wide range of Prizer's offerings. While API refers to the component of the drug that causes the intended effect, FDF refers to the finished drug that is meant for consumption. ....
As new variants of Covid emerged, vaccine developers planned to update their original vaccines, but the arrival of the fast-spreading Omicron strain in the ....
देश में कोरोना वायरस के खिलाफ लड़ाई में भारत को जल्द ही एक और हथियार मिल सकता ह। टीकाकरण अभियान को India is in talks to buy 50 million doses of Pfizer Covid-19 vaccine Wall Street Journal reported - India News - Hindustan ....
As soon as Pfizer indicated vaccine availability, the central government and the company started working together for the earliest possible import of the vaccine, NITI Aayog member VK Paul said on Thursday. ....
Pfizer s vaccine 91% effective in preventing Covid, updated trial data shows Pfizer s vaccine 91% effective in preventing Covid, updated trial data shows Updated clinical trial data shows that Pfizer and BioNTech s vaccine is 91 per cent effective at preventing Covid-19. The vaccine also showed early signs of guarding recipients against the South African variant. advertisement File photo of Pfizer and BioNTech s Covid-19 vaccine (Photo Credits: AP) HIGHLIGHTS Pfizer s vaccine is currently authorized on an emergency basis by the US FDA The trial reviewed more than 900 confirmed cases of Covid-19 Pfizer Inc and BioNTech said on Thursday their vaccine is around 91 per cent effective at preventing Covid-19, citing updated trial data that included participants inoculated for up to six months. ....